All the news Showing 10 of 62 articles from: Treatment for people who use drugsGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Hepatitis C treatment and prevention failing to reach people most affected Keith Alcorn / 25 February 2020 Major gaps in harm reduction and treatment provision for people who inject drugs jeopardise the achievement of global targets for hepatitis C elimination by 2030, a review of hepatitis C treatment and ... Half of people who inject drugs in Middle East have hepatitis C Keith Alcorn / 24 February 2020 Half of people who inject drugs in the Middle East and north Africa have been infected with hepatitis C, and researchers from Weill Cornell Medicine Qatar estimate that around 221,000 people who ... Increase in clean needle and syringe provision essential for hepatitis C elimination Keith Alcorn / 12 February 2020 Elimination of hepatitis C will not be achievable without substantial improvements in provision of sterile injecting equipment, Dr Magdalena Harris of London School of Hygiene and Tropical Medicine told a conference on hepatitis ... London: hepatitis C elimination depends on testing scale-up Keith Alcorn / 28 January 2020 London needs to step up the rate of testing for hepatitis C if it is to achieve elimination of hepatitis C, Professor Graham Foster of Queen Mary University London told the London ... People who use drugs would prefer to get hepatitis C treatment at a community pharmacy Keith Alcorn / 04 October 2019 Seventy-eight per cent of people using needle and syringe programmes in community pharmacies in London who opted to test for hepatitis C would prefer to receive their hepatitis C treatment from the ... Hepatitis C treatment in primary care delivers higher cure rate for people who inject drugs Keith Alcorn / 08 July 2019 Providing treatment for hepatitis C in the primary care setting significantly improves the uptake of treatment and cure rates in people who inject drugs, a randomised study conducted in Australia and New ... What do people who inject drugs think of point-of-care HCV testing? Keith Alcorn / 20 May 2019 Point-of-care testing to diagnose hepatitis C virus (HCV) infection has the potential to eliminate the need for multiple appointments to confirm chronic infection. An oral antibody test can provide a result in ... World Health Organization calls for greater focus on people who inject drugs in HCV treatment scale-up plans Keith Alcorn / 30 April 2019 The World Health Organization (WHO) has called for greater commitments to scale up hepatitis C virus (HCV) testing and treatment services to people who inject drugs and people in prisons. In an analysis ... HCV reinfection in people who inject drugs a sign of a successful treatment programme, say researchers Keith Alcorn / 11 March 2019 High rates of reinfection in people who inject drugs are a sign that access to treatment is improving, not a sign of failure, and should prompt retreatment, not stigmatisation, Australian hepatitis researcher ... Access to hepatitis C care boosted for people who inject drugs by specialist nurses Keith Alcorn / 19 February 2019 People attending specialist addiction centres in England where a facilitator enabled access to hepatitis C care services were ten times more likely to be referred to hepatology services and to start treatment ... ← Prev12345...7Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive